<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Ophthalmology: Skin Cancer Topic Collection</title>
    <link>http://archopht.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Thu, 02 May 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Thu, 02 May 2013 16:47:47 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archopht.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archopht.jamanetwork.com</webMaster>
    <item>
      <title>Management of Occult Necrotic Melanomas</title>
      <link>http://archopht.jamanetwork.com/article.aspx?articleID=1682371</link>
      <pubDate>Thu, 02 May 2013 00:00:00 GMT</pubDate>
      <author>Char DH, Cole TB, Crawford J. </author>
      <description>&lt;span class="paragraphSection"&gt;As many as 20% of uveal melanoma–containing eyes historically had opaque media and more than half of such tumors were unsuspected. While many ophthalmic oncologic centers, including ours, have more than 99% accuracy of uveal melanoma diagnosis, in eyes with opaque media and extensive necrosis the correct diagnosis can sometimes be impossible to establish with ultrasonography, magnetic resonance imaging (MRI), and fine-needle aspiration biopsy (FNAB). We present 5 cases that illustrate these problems.&lt;/span&gt;</description>
      <prism:startingPage xmlns:prism="prism">1</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">3</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamaophthalmol.2013.231</prism:doi>
      <guid>http://archopht.jamanetwork.com/article.aspx?articleID=1682371</guid>
    </item>
  </channel>
</rss>